https://www.selleckchem.com/EGFR(HER).html
15% of negative patients had severe AP (p 0.03). We established that being COVID-19 positive, CCI scores of ≥5, presence of COVID-19 compatible pneumonia on CT and BISAP scores had an effect on mortality (p 0,05). The severity and mortality of AP increase in patients with both AP and COVID-19. This rate increases even more in the presence of COVID-19-associated pneumonia. We believe that new strategies should be developed for the follow-up and treatment of patients with both these conditions. The severity and mortality of AP increase
Curtir
Comentario
Compartilhar
